Pharmafile Logo
Pharmafocus logo
Advanced Search

Imbruvica combo scores expanded FDA approval in most common adult form of leukaemia

January 29, 2019
Manufacturing and Production, Sales and Marketing AbbVie, Cancer, Janssen, imbruvica, leukaemia, pharma

It’s big news for Janssen and AbbVie as it emerged that their jointly-developed Bruton’s tyrosine kinase (BTK) inhibitor Imbruvica (ibrutinib) …

News
800px-t_lymphocyte_16760076824

Precision cancer treatment for dogs moves towards human testing

January 29, 2019
Manufacturing and Production CAR-T therapy, Cancer, Precision Medicine, car t therapy, dogs, t cells, t-cells

Scientists at the University of Missouri have developed a patient specific, precision medicine treatment for bone cancer in dogs. The …

News
shutterstock_168864905

Destiny Pharma secures £1.6m grant to fight ‘superbugs’ and antimicrobial resistance

January 29, 2019
Manufacturing and Production, Research and Development Destiny Pharma, antimicrobial resistance, pharma

UK biotech Destiny Pharma has secured £1.6 million in funding to further its research into the prevention and elimination of …

News
1280px-old_surgical_hospital_drummond_street

Edinburgh researchers genetically modify chickens to produce medicine filled eggs

January 29, 2019
Manufacturing and Production Edinburgh, cancer drugs, medicines, monoclonal antibodies, proteins

Researchers at the University of Edinburgh have genetically modified chickens, meaning that they lay eggs containing human proteins which can …

News
alexander_hardy

Alexander Hardy returns to Genentech as new CEO

January 28, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Genentech, Roche, appointment, pharma

Genetech, the biotech subsidiary of Swiss firm Roche, has named its new CEO, revealing that Alexander Hardy will be returning …

News

Philip Hampton to step down from chairman role at GSK

January 28, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, UK, appointment, pharma

Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just …

Appointment

Novartis warns of huge impact of no-deal Brexit

January 28, 2019
Sales and Marketing EU, Novartis, UK, brexit, no-deal, pharma

Swiss pharmaceutical company Novartis has called on the British government to ‘ensure continuity of supply’ in the case of a …

News
dw-anzcxqaqavhl

Head of opioid advisory panel criticises FDA for complacency in ongoing crisis

January 28, 2019
Medical Communications, Sales and Marketing Dsuvia, FDA, opioid crisis, opioids, pharma

The opioid crisis continues to be a top healthcare concern in the US, but the head of the FDA’s Anesthetic …

News

People in England will be able to pay the NHS to sequence their genetic data, if they share it with scientists

January 28, 2019
Sales and Marketing Alzheimer's, Cancer, England, NHS, genetic data, genomes, health

The NHS will provide paid-for health reports, informing patients as to the likelihood that they will develop diseases such as …

News
allergan

Allergan and St Regis Mohawk Tribe take patent ruling to Supreme Court

January 28, 2019
Sales and Marketing Allergan, Mohawk, Restasis, St Regis, eye drops, patents

Allergan and the St Regis Mohawk Tribe have asked the Supreme Court to defend a 2017 patent agreement which would …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

January 25, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Celgene, NHS, health, pharma, venlytxo

While American firm AbbVie gained approval for leukaemia drug Venlytxo, the NHS defeated the US multinational thus week in court, …

News

Bristol-Myers Squibb withdraws lung cancer combo therapy marketing application

January 25, 2019
Medical Communications BMS, Merck, Yervoy, ctla4, lung cancer, opdivo

Bristol-Myers Squibb has been forced to withdraw a marketing application for its combination of Opdivo and Yervoy for lung cancer. …

News
amgen_flag

China’s NMPA approves Amgen’s Repatha to reduce cardiovascular event risk

January 25, 2019
Medical Communications, Sales and Marketing Amgen, China, Repatha, cardiovascular disease, pharma, stroke

Amgen has announced that its proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor Repatha (evolocumab) has secured approval by China’s drug …

News

Diagnosis at stages 1-3 increases cancer survival rate significantly

January 25, 2019
Medical Communications Cancer, England, NHS, health, oncology

Adults diagnosed with stage 1 skin, prostate or breast cancer have the same chance of still being alive the following …

News
nhs_sign

NHS App begins public rollout across England following successful testing

January 24, 2019
Medical Communications England, NHS, NHS App, UK, health, pharma

NHS England has announced that the NHS app, which will allow patients to book and manage their GP appointments alongside …

News
antibiotic_sensitvity_and_resistance

UK government launches plan to control AMR by 2040

January 24, 2019
Medical Communications, Research and Development AMR, Antibiotics, Davos, Matt Hancock, UK

The British government has announced a plan through which it will incentivise pharmaceutical companies to develop drugs aimed at tackling …

News

EMA rejects Lilly’s Lartruvo in soft tissue cancer following trial failure

January 24, 2019
Sales and Marketing Cancer, EMA, Eli Lilly, Lartruvo, pharma

Eli Lilly has been dealt a blow as the European Medicines Agency announced its recommendation for soft tissue cancer patients …

News
vertex-headquarters

Vertex ousts COO Ian Smith over ‘personal behaviour’

January 24, 2019
Business Services Ian Smith, Jobs, Vertex, executives

Boston-based firm Vertex Pharmaceuticals has fired Chief Operating Officer (COO) and interim Chief Financial Officer (CFO) Ian Smith. Smith’s termination, …

News

Irish Pfizer employees to launch industrial action ballot over pensions scheme

January 24, 2019
Manufacturing and Production Ireladn, Pfizer, cork, industrial action, manufacturing, strike

Pfizer employees have rejected a Labour Court recommendation regarding their pension scheme, opting to initiate a ballot over potential industrial …

News

Cost of insulin doubled between 2012 and 2016

January 23, 2019
Research and Development USA, healthcare, insulin, insurance, pricing

The cost of insulin almost doubled in the United States between 2012 and 2016, according to a report by the …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026